The digital transformation has brought many technologies for the industries that help to enhance organisations’ performance, transparency and security levels.
Sandoz, a global leader in generic and biosimilar medicines, declared the US launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, an AB-rated generic equivalent to AbbVie’s Combigan...
Soon a two-shot Covid-19 vaccine of Zydus Cadila could be rolled out, instead of the three-shot regimen currently approved.
Britain's medicines regulator on Thursday permitted the use of Moderna's COVID-19 vaccine in children between six and 11 years, as the country bolsters itself for fighting coronavirus infections amid the spread of new virus variants.
Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids. US health authorities already urge everyone 12 and older to get one booster dose for the best safety against the newest variants.
In a deal that will strengthen its emphasis on the delivery of drugs, Halozyme Therapeutics Inc. offered to acquire specialised biopharmaceutical business Antares Pharma Inc. for roughly 1 billion dollars.
Akums Drugs & Pharmaceuticals Ltd has newly acquired a facility from Ankur Drugs and Pharmaceuticals Limited.
India's pharmaceutical companies will get an easy access to launch their products in the Australian market, with Therapeutic Goods Administration the drug regulatory authority in Australia agreeing to expedite faster and easier approvals for India's
Britain’s GlaxoSmithKline has agreed to buy California-based biopharmaceutical firm Sierra Oncology in a cash deal valued at $1.9 billion, the companies said on Wednesday, as it seeks to bolster its blood cancer business.
Developing pharmaceuticals through lengthy and costly clinical trials is definitely an approach which is here since long.
, CDSCO.jpg)
